Discover trends, market shifts, and competitive outlooks for the kidney disease industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Kidney Disease Market From 2025 To 2029?

In recent times, the market size for kidney disease has seen robust growth. There will be a rise from $107.29 billion in 2024 to $114.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.9%. Factors such as escalating chronic health conditions, an aging populace, genetic susceptibility, advancements in medical research and education, coupled with environmental variables have contributed to the growth during the historic period.

The market for kidney disease is anticipated to experience significant expansion in the coming years, with a projected value of $149.44 billion in 2029 and a compound annual growth rate (CAGR) of 6.8%. This projected growth during the forecast period is believed to be driven by factors such as worldwide management of infectious diseases, precision medical treatments, an uptick in diabetes and obesity, healthcare policy shifts, and advancement in awareness and screening. Key trends during this period are expected to include the adoption of telemedicine for kidney health, a focus on preventive nephrology, the emergence of at-home dialysis, the progression of regenerative therapies, and changes in diet and nutrition.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What Are the Core Growth Drivers Propelling the Kidney Disease Market Forward?

The surge in kidney-related ailments is predicted to boost the kidney disease market’s expansion. The term “kidney diseases” encompasses various conditions that impair the kidneys’ functioning and structure. Medications for kidney conditions serve to decrease blood pressure in patients, limit protein loss, slow kidney damage progression, manage symptoms, and ward off complications. For instance, in June 2023, Kidney Research UK, a UK-based charitable organization dedicated to research and advocacy in kidney diseases, disclosed that approximately 7.19 million individuals in the UK suffered from chronic kidney disease in 2023, equating to over 10% of the UK population. This figure is forecasted to rise to 7.61 million individuals by 2033. Hence, the escalating prevalence of kidney diseases is fueling the growth of the kidney disease market.

What Segment Types Define the Kidney Disease Market Structure?

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Kidney Disease Market?

North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theKidney Disease Industry Evolution?

The adoption of AI-based tools in the kidney disease market is a prominent trend gaining traction. Businesses in this sector are embracing innovative technologies to enhance patient results and maintain their market standing. For example, Carenostics, a healthcare startup from the US that specializes in AI solutions, unveiled its premiere product in November 2022. This product is engineered to sift through electronic health record (EHR) data to detect early signs of chronic kidney disease (CKD). The company’s integration of AI-backed clinical decision support models into healthcare providers’ EHR systems allows doctors to pinpoint patients at high risk for chronic illnesses, thus facilitating early intervention for better patient outcomes.

View the full report here:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

What Is the Definition of the Kidney Disease Market?

Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. The kidneys are vital organs responsible for filtering waste and excess fluids from the blood, regulating electrolyte balance, and producing hormones that control blood pressure and red blood cell production.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model